Pentwater Capital Management LP Cerevel Therapeutics Holdings, Inc. Call Options Transaction History
Pentwater Capital Management LP
- $7.74 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CERE
# of Institutions
147Shares Held
127MCall Options Held
1.91MPut Options Held
2.7M-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2MShares$00.04% of portfolio
-
Marshall Wace, LLP London, X01.87MShares$00.11% of portfolio
-
Segantii Capital Management LTD1.14MShares$05.99% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il956KShares$00.01% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...